SR ONE CAPITAL MANAGEMENT, LP Long-Term Concentrated

Location: Redwood City, CA

CIK: 0001910264 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 13, 2024

Total Value: $499M (100.0% shares, 0.0% debt)

Holdings (11)

ACLX Arcellx, Inc. 39.3%

Value $196M Shares 2,346,630 Est. Cost $16.72 Unrealized +298.3%

ZBIO Zenas BioPharma, Inc 16.7%

Value $83.1M Shares 4,911,539 Est. Cost $17.98 Unrealized 0.0%

SPRY ARS Pharmaceuticals, Inc. 11.7%

Value $58.19M Shares 4,012,903 Est. Cost $6.79 Unrealized +75.2%

CRSP CRISPR Therapeutics AG 9.9%

Value $49.28M Shares 1,048,951 Est. Cost $71.59 Unrealized -29.1%

DSGN Design Therapeutics, Inc. 7.0%

Value $35.11M Shares 6,526,476 Est. Cost $16.67 Unrealized -71.8%

MLYS Mineralys Therapeutics Inc. 4.9%

Value $24.42M Shares 2,016,822 Est. Cost $16.34 Unrealized -25.9%

ALMS Alumis Inc. 4.2%

Value $20.93M Shares 1,959,896 Est. Cost $13.30 Unrealized -8.8%

NKTX Nkarta, Inc. 3.0%

Value $15.07M Shares 3,333,333 Est. Cost $11.49 Unrealized -50.5%

ORKA Oruka Therapeutics, Inc 1.8%

Value $9.199M Shares 375,330 Est. Cost $34.79 Unrealized 0.0%

ENGN enGene Holdings Inc. 1.0%

Value $4.935M Shares 747,750 Est. Cost $11.04 Unrealized -32.6%

KALA KALA Bio, Inc. 0.5%

Value $2.529M Shares 443,661 Est. Cost $6.61 Unrealized -4.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	Arcellx, Inc.	2,346,630	$196M	39.3%	$16.72	+298.3%	Common Stock	03940C100
ZBIO	Zenas BioPharma, Inc	4,911,539	$83.1M	16.7%	$17.98	0.0%	Common Stock	98937L105
SPRY	ARS Pharmaceuticals, Inc.	4,012,903	$58.19M	11.7%	$6.79	+75.2%	Common Stock	82835W108
CRSP	CRISPR Therapeutics AG	1,048,951	$49.28M	9.9%	$71.59	-29.1%	Common Shares	H17182108
DSGN	Design Therapeutics, Inc.	6,526,476	$35.11M	7.0%	$16.67	-71.8%	Common Stock	25056L103
MLYS	Mineralys Therapeutics Inc.	2,016,822	$24.42M	4.9%	$16.34	-25.9%	Common Stock	603170101
ALMS	Alumis Inc.	1,959,896	$20.93M	4.2%	$13.30	-8.8%	Common Stock	022307102
NKTX	Nkarta, Inc.	3,333,333	$15.07M	3.0%	$11.49	-50.5%	Common Stock	65487U108
ORKA	Oruka Therapeutics, Inc	375,330	$9.199M	1.8%	$34.79	0.0%	Common Stock	687604108
ENGN	enGene Holdings Inc.	747,750	$4.935M	1.0%	$11.04	-32.6%	Common Shares	29286M105
KALA	KALA Bio, Inc.	443,661	$2.529M	0.5%	$6.61	-4.5%	Common Stock	483119202